Nykredit A/S’s Edwards Lifesciences EW Stock Holding History

Nykredit A/S’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.6M	Buy	+228,193	New	+$19.1M	0.06%	233

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Nykredit A/S's EW Position: Q2 2026 in Review

Nykredit A/S opened a new position in Edwards Lifesciences (EW) in Q2 2026: 228,193 shares worth $20.6M. The stake represents 0.06% of the portfolio and ranks #233 among its holdings.

1,086 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Nykredit A/S held 228,193 shares of Edwards Lifesciences worth $20.6M as of Q2 2026.
Edwards Lifesciences was a new Nykredit A/S position in Q2 2026.
Edwards Lifesciences made up 0.06% of Nykredit A/S's portfolio in Q2 2026, its #233 holding.
1,086 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.